Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Previous reports have suggested that some probiotics inhibit tumorigenesis and cancer progression. However, the molecules involved have not yet been identified. Here, we show that the culture supernatant of Lactobacillus casei ATCC334 has a strong tumour-suppressive effect on colon cancer cells. Using mass spectrometry, we identify ferrichrome as a tumour-suppressive molecule produced by L. casei ATCC334. The tumour-suppressive effect of ferrichrome is greater than that of cisplatin and 5-fluorouracil, and ferrichrome has less of an effect on non-cancerous intestinal cells than either of those agents. A transcriptome analysis reveals that ferrichrome treatment induces apoptosis, which is mediated by the activation of c-jun N-terminal kinase (JNK). Western blotting indicates that the induction of apoptosis by ferrichrome is reduced by the inhibition of the JNK signalling pathway. This we demonstrate that probiotic-derived ferrichrome exerts a tumour-suppressive effect via the JNK signalling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One good example is ferricrome metabolite secreted from Lactobacillus casei, able to trigger apoptosis in tumor cells via JNK pathway direct activation [44].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432
Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Van Nhieu, J. T., & Furet, J. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016393 · Cited by 842
Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K., & Polk, D. B. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.022 · Cited by 827
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., Timofeeva, O. A., Nealon, C., Dakic, A., Simic, V., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.036 · Cited by 726
New roles for bacterial siderophores in metal transport and tolerance
Schalk, I. J., Hannauer, M., & Braud, A. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02556.x · Cited by 580
Towards the Human Colorectal Cancer Microbiome
Marchesi, J. R., Dutilh, B. E., Hall, N., Peters, W. H. M., Roelofs, R., Boleij, A., & Tjalsma, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020447 · Cited by 552
Rowland, I. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.281 · Cited by 469
Jan, G., Belzacq, A.-S., Haouzi, D., Rouault, A., Métivier, D., Kroemer, G., & Brenner, C. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400935 · Cited by 385
Cited by
Items 201–286 of 286
Probiotics as an Adjunct Approach to the Prevention and Treatment of Colon Cancer: A Review
Kumar, A., Goyal, N., Pramanik, J., Bawa, Y., Singh, S. K., & Prajapati, B. G. (2024) · Current Nutrition & Food Science · doi:10.2174/0115734013270901231124063616 · Cited by 5
Metabiotics in Colorectal Cancer: Crosstalk Between Gut Microbiota and Host Pathology
Gulati, M., Singh, S. K., Kumar, R., Dua, K., Panda, S., Blaxland, J., & Chandwani, L. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_5 · Cited by 5
Microbiota intestinal y cáncer
Veintimilla, D. R., & Frías-Toral, E. (2021) · Revista de Nutrición Clínica y Metabolismo · doi:10.35454/rncm.v4n1.175 · Cited by 10
Intestinal dysbiosis – a new treatment target in the prevention of colorectal cancer
Dumitru, F.-A., Micu, S. I., Popoiag, R., Musat, M., Caloian, A.-D., Calu, V., Constantin, V. D., Bălan, D., Niţipir, C., & Enache, F. (2021) · Journal of Mind and Medical Sciences · doi:10.22543/7674.82.p221228 · Cited by 5
“For example, butyrateproducing species such as Clostridium butyricum and Bacillus subtilis may have an anti-tumor effect; Lactobacillus casei (strain BL23) may suppress colorectal cancer by targeting intestinal dysbiosis [66], while Lactobacillus casei (strain ATCC 334) produce ferrochrome which prevents colorectal ca…”
BackgroundOchi, N., Ichihara, E., Yokoyama, T., Inoue, K., Tamura, T., Watanabe, H., Takata, I., Kano, H., Nakamura, K., Kawai, H., et al. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02860-9 · Cited by 5
Abdorrashidi, M., Heiat, M., Yeganeh, A. V., Tohidinia, A., Alizadeh, A., Ramazani, A., Gholizadeh, H., Pouraskar, T., & Peypar, M. H. (2025) · BioMed Research International · doi:10.1155/bmri/4216722 · Cited by 4
“Notably, this strain demonstrated the most potent tumor-suppressive activity among the tested Lactobacillus species [40].”
Synthesis and biological evaluation of echinomycin analogues as potential colon cancer agent
Kojima, K., Konishi, H., Momosaki, K., Komatani, Y., Katsuyama, A., Nakagawa, K., Kanamitsu, K., Yakushiji, F., Fujiya, M., & Ichikawa, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-58196-3 · Cited by 5
“These compounds were synthesized from sulfoxide 23 in a manner similar to the total synthesis of 1 , via a scheme that was developed by our group 20 .”
MethodResultInfluentialThe Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer
Bonvalet, M., Daillère, R., Roberti, M. P., Rauber, C., & Zitvogel, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_27 · Cited by 5
Microbial Avengers: How Microorganisms Drive Angiogenesis for Good and Bad?
Fakruddin, M., Chowdhury, Z., Shibly, S. U. A., Islam, S. B. U., Jime, J. S., Bulbul, N., Anam, M. B., Mannan, K. S. B., & Shishir, M. A. (2024) · Journal of Angiotherapy · doi:10.25163/angiotherapy.859650 · Cited by 5
Sun, W., Ma, S., Meng, D., Wang, C., & Zhang, J. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13498 · Cited by 7
“Konishi et al (172) investigated a probiotic‑derived tumor suppressor molecule known as iron‑chromium, which inhibits colon cancer progression via JNK‑mediated pathways.”
Probiotics in Lung Cancer: An Emerging Field of Multifarious Potential and Opportunities
Kurakula, M., & Rao, G. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_7 · Cited by 4
Soopramanien, M., Khan, N. A., & Siddiqui, R. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14981 · Cited by 4
Agraib, L. M., Yamani, M. I., Rayyan, Y. M., Sneineh, A. T. A., Tamimi, T., & Tayyem, R. (2021) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmdi-2021-0150 · Cited by 21
Prebiotics and Probiotics in Altering Microbiota
Purama, R. K., Raman, M., Ambalam, P. S., Pithva, S. P., Kothari, C., & Doble, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805417-8.00030-5 · Cited by 4
Diet, microbes, and cancer across the tree of life: a systematic reviewPreprint
Kapsetaki, S. E., Alcaraz, G. M., Maley, C. C., Whisner, C. M., & Aktipis, A. (2021) · Research Square · doi:10.21203/rs.3.rs-1077771/v1 · Cited by 4
Genome Editing Using the Endogenous Type I‐E CRISPR‐Cas System in Lactobacillus paracasei ATCC334
Zuo, N., Zuo, F., Liu, Y., & Xiang, B. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70056 · Cited by 3
Gut Microbiota and Cancer Correlates
Malaviya, A., Paari, K. A., Malviya, S., Kondapalli, V. K., Ghosh, A., & Samuel, R. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_1 · Cited by 5
Microbiome Diagnostics and Interventions in Health and Disease
Dasgupta, N., Srivastava, A., Rao, A., Murugkar, V., Shroff, R., & Das, G. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_10 · Cited by 5
Human microbiota: role in cancer progression and therapy
Rais, A., Chand, P., Malik, M., & Prasad, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96128-8.00006-7 · Cited by 3
Role of lactic acid bacteria in maintaining animal intestinal health
Han, X., Yuan, X., Jun, F. A. N. G., Jiang, H., & Liu, G. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0032 · Cited by 4
Kashyap, S., & Das, A. (2023) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2023.02054 · Cited by 5
Iron Harvesters: Exploring Microbial Siderophores and Their Diverse Applications in Biomedicine
Khairnar, A., & Goyal, A. K. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-024-00189-x · Cited by 5
The Human Microbiome: An Emerging Key Player in Health and Disease
Blum, H. E. (2017) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.5017009 · Cited by 4
Guo, X., Zou, X., Xu, H.-L., & Gu, J. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3620892 · Cited by 2
“However, accumulating evidence indicates that disturbance of the microbiome is closely associated with various diseases, such as diabetes [3], multiple sclerosis [4], neurological disorders [5], obesity [6], and cancers [7].”
The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review
Tang, C., Qian, Y., Jia, S., Zhang, J., Zhang, Y., Ren, Y., Yong, H., Xu, J., Kan, J., & Liu, J. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10753-6 · Cited by 2
Sun, T., Zhang, Q., Dai, Y., Liu, Y., Teng, X., & Li, J. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124015 · Cited by 4
An Insight on Gut Flora, Colorectal Cancer Mechanism, and Treatment Strategies
Kumar, R., Kaur, A., & Rajput, D. (2023) · Advanced Gut & Microbiome Research · doi:10.1155/2023/7429949 · Cited by 4
“…spp., demonstrated anticancer properties through various mechanisms [163], including inhibiting cell proliferation [164, 165], inducing cancer cell apoptosis [166, 167], modulating host immunity [168, 169], inactivating carcinogenic toxins [170, 171], and producing anticarcinogenic compounds [172].”
BackgroundCan buttermilk (ayran) with its postbiotic content be used in the protection of colon health?
Çelebi, L. T., Bursalıoğlu, E. O., Çakıcı, B., Genel, N., Kalbişen, H. T., & Aslan, İ. (2025) · Journal of Immunology and Clinical Microbiology · doi:10.58854/jicm.1606939 · Cited by 5
Microbiota intestinal: el órgano olvidado
Rivera, J. A. M., Pacheco, S. T., Greene, E. J. D., & Weber, F. L. R. (2021) · Acta Médica Grupo Ángeles · doi:10.35366/98577 · Cited by 39
Recently Progressed Postbiotics as Nutraceuticals
Jeong, G. (2021) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2021.1.e33 · Cited by 2
Gut Microbiota Modulation: Probiotics and Prebiotics in GI Cancer
Au-Doung, P. L. W., Chan, R. H., Wu, W. K. K., & Li, Q. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_14 · Cited by 2
Microbiome in Colorectal Cancer
Huang, P., & Wong, C. C. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_3 · Cited by 3
Kwon, S. K., Kim, N., & Park, Y. J. (2021) · International Journal of Thyroidology · doi:10.11106/ijt.2021.14.2.117 · Cited by 1
Hadid, M. A., Al-Shaibani, A. B. A., & Al-Halbosiy, M. M. F. (2023) · Journal of AL-Farabi for Medical Sciences · doi:10.59746/jfms.v1i1.24 · Cited by 1
Human microbiome, cancer and cancer therapy
Veerasamy, R., Karunakaran, R., & Vasu, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15435-5.00007-4 · Cited by 1
Biological Roles of MAP Kinases
De, S. K. (2024) · Springer eBooks · doi:10.1007/978-3-031-75682-5_2 · Cited by 1
Behbahani, B. A., Hojjati, M., & Shamsabadi, B. G. (2025) · Journal of Nutrition Sciences and Food Technology · doi:10.61882/nsft.20.3.95 · Cited by 1
Microbiome: A Novel Therapeutics in Cancer Management
Oniyangi, A. G., & Nazir, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00004-8 · Cited by 1
Cubillos, S. I., & Tewfik, I. (2022) · Journal of Food Research · doi:10.5539/jfr.v11n2p35 · Cited by 1
Healthy gut microbiome in the prevention of colorectal cancer
Rumman, M., Nagasaka, M., Al-Share, B. A., Azmi, A. S., & Uddin, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00005-4 · Cited by 1
Feng, N., Wang, S., Liu, C., Xu, Z., Song, Z., Li, K., & Yu, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1069780 · Cited by 1
Colon-specific delivery of nutraceuticals
Krishnamoorthy, S., Zongo, K., Moses, J. A., & Anandharamakrishnan, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824312-1.00012-1 · Cited by 1
Postbiotics and their therapeutic effects: a review
Köktürk, S. N., & Yardımcı, H. (2023) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000383 · Cited by 2
An NIR‐Fluorophore‐Based Inhibitor of SOD1 Induces Apoptosis by Targeting Transcription Cofactor PC4
Luo, P., Tan, X., Luo, S., Wang, Z., Long, L., Wang, Y., Liao, F., Chen, L., Zhang, C., He, J., et al. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800148 · Cited by 1
Jam, S. A. M., Khosroushahi, A. Y., Alipour, M., & Alipour, B. (2020) · Journal of Research in Clinical Medicine · doi:10.34172/jrcm.2020.008 · Cited by 1
Li, Y., Zhang, Y., Zhang, W., Wei, C., Wei, W. A. N. G., Zhao, D., Zhou, D., & Li, J. (2021) · Research Square · doi:10.21203/rs.3.rs-604208/v1 · Cited by 1
Mechanism of Action of Probiotics
Pooja, S., Niranjan, V., Setlur, A. S., Chandrashekar, K., & Skariyachan, S. (2026) · Wiley eBooks · doi:10.1002/9781394269082.ch18 · Cited by 1
The Microbiome in Liver Diseases
Blum, H. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_19
The Role of Synbiotics in Alleviating Oxidative Stress in Colorectal Cancer
Gulati, M., Singh, S. K., & Singh, A. (2020) · Springer eBooks · doi:10.1007/978-981-15-1568-2_6
Chen, S., Fan, L., Lin, Y., Qi, Y., Xu, C., Ge, Q., Zhang, Y., Wang, Q., Jia, D., Si, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1607997/v1
Potential of Biobased Technologies in Nutraceuticals for the Prevention and Treatment of Cancer
Egea, M. B., Campos, S. B., Martins, L. C. G., Guariglia, B. A. D., Oliveira, A. C. D. J., Brandão, A. D. A., Fernandes, A. C. X. P. D. M., Couto, L. S., Dusi, C. F. D. S., da Silva, A. L. A., et al. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839168048-00189
Unraveling the Cancer Metabolism: Fasting Reset, Ketogenic Diet and Therapeutic Strategies
Tenenbaum, G., Berg, E. P., & Israël, M. (2023) · Journal of Cancer Research Reviews & Reports · doi:10.47363/jcrr/2023(5)176
Imtiyaz, F. D. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.411
Pethakamsetty, L., Pola, S., & Giduthuri, J. G. (2023) · Springer eBooks · doi:10.1007/978-981-99-5114-7_13
Gut microbiome as a tumor promoter and tumor suppressor
Yadav, T., Syal, R., & Tripathi, C. (2023) · Microsphere · doi:10.59118/yqei2382
A Review on Probiotics and Their Role in the Management of Cancer
Dahiya, R., Khan, S., & Kumar, S. (2024) · Current Probiotics · doi:10.2174/0126666499270987231218145156
Microbioma intestinal versus Câncer Colorretal
Fernandes, M. G. D. S., dos Reis, E. B. B., Perini, H. F., Neto, J. M., Miguel, C. B., & Felipe, A. G. B. (2024) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.17n.1-202 · Cited by 1
The Association Between Intestinal Flora and Lung Cancer and the Regulatory Role of Dietary Fiber
Wu, H. (2024) · Highlights in Science Engineering and Technology · doi:10.54097/p06r5454
“IF related vitamin B6 can cooperate with cisplatin and other chemotherapy drugs to kill NSCLC cells, and jointly mediate the immune-dependent anti-tumor effect[12].”
BackgroundMicrobiome and colorectal cancer drug resistance
Miya, T. V., Belancio, V. P., & Dlamini, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-33475-7.00016-0
Mikrobiotika und Prä-, Pro- und Postbiotika
Jacobi, C. A. (2024) · Springer eBooks · doi:10.1007/978-3-662-68455-9_20
Tan, H., Yao, H., & Nie, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21630-5.00003-4
The Influence of Prebiotics and Probiotics in Colorectal Cancer Treatment
Ahmed, N. A., Khalil, R. G., Yassin, N. Y. S., & Ahmed, O. M. (2024) · Springer eBooks · doi:10.1007/978-981-96-0297-1_7
GUT MICROBIOME IN CANCER: THE NEXT BIG OPPORTUNITY FOR BETTER PATIENT OUTCOMES?
Povšin, J., Sotošek, T., Novak, M., & Breznik, B. (2025) · Slovenian Veterinary Research · doi:10.26873/svr-2029-2024
“For instance, Lactobacillus casei produces ferrichrome, which activates the c-Jun N-terminal kinase signaling pathway and ultimately induces programmed cell death in cancer cells (55).”
Chen, H., Wang, J., Zhang, X., Chen, Z., Zhang, H., Su, C., & Li, B. (2025) · Interdisciplinary Nursing Research · doi:10.1097/nr9.0000000000000088
“In the gut, they may exert their effects by reducing in fl ammation, promoting the growth and fermentation of probiotics, and preventing pathogen colonization 86 .”
He, L., Tan, D., Zhu, R., Zhao, J., Yin, H., Duan, M., Li, X., Fan, W., Yang, Z., Wang, X., et al. (2025) · Współczesna Onkologia · doi:10.5114/wo.2025.148642
“Similarly, a variety of lactobacilli exert anti-cancer effects by inhibiting tumour growth and promoting apoptosis [20, 35, 36].”
Ray, P., Taj, T., De, S., Dhingra, R., Kumar, T., Dey, S., Mukherjee, S., Debnath, B., Ashique, S., & Smaoui, S. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-86065-2_20 · Cited by 1
Ahamad, R., Ali, A., Manna, P., Quadri, N., Khan, Z., Pal, R., Muztaba, M., Ghazanfar, S., Islam, A., Iqbal, A., et al. (2025) · Wiley eBooks · doi:10.1002/9781394313785.ch10
Protein-based oral delivery system of probiotics
Chatterjee, A., & Dutta, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27594-4.00004-8
Konishi, H., Fukui, S., Dokoshi, T., Tanaka, H., Kashima, S., Sakatani, A., Takahashi, K., Ando, K., Ueno, N., Moriichi, K., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118436
Therapeutic advances: Modulating gut microbiota, ROS, and SCF pathways in cancer treatment
Giri, S., Irfan, Z., & Firdous, S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00010-7
Sahu, G., Pandey, A. K., & Goyal, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00004-1
Bioactive compounds of probiotics against cancer
Yalçınkaya, S., & Karahan, A. G. (2025) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49150-4.00002-x
Qi, Z., Zhibo, Z., Jing, Z., Zhanbo, Q., Shugao, H., Weili, J., Jiang, L., & Han, S. (2023) · Figshare · doi:10.6084/m9.figshare.22601968
Additional file 1 of Microbial signatures and continuum in endometrial cancer and benign patients
Semertzidou, A., Whelan, E., Smith, A., Ng, S. Q. Y., Roberts, L. A., Brosens, J. J., Marchesi, J. R., Bennett, P. R., MacIntyre, D. A., & Kyrgiou, M. (2024) · Figshare · doi:10.6084/m9.figshare.26143658
Qi, Z., Zhibo, Z., Jing, Z., Zhanbo, Q., Shugao, H., Weili, J., Jiang, L., & Han, S. (2023) · Figshare · doi:10.6084/m9.figshare.22601965
Biliary stents can modify the microbiota and promote the progression of pancreatic cancer
Fiordaliso, M., Pala, B., Marincola, G., Piscione, M., Savino, L., Mazzone, M., Marcantonio, M. C. D., & Mincione, G. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1633611 · Cited by 1
Mechanisms of action of probiotics and prebiotics
Dhiman, N. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00031-5
Functional Role of Lactobacillus in Cancer Prevention
Gopalakrishnan, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014581
Cueva-Yesquén, L. G., Martins, K. M. D. C., Hidalgo, K., Sartoratto, A., de Oliveira, A. D. S. S., de Melo, I. S., & Fantinatti‐Garboggini, F. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05210-5
“Although this cluster is commonly found in fungi, it has also been detected in Lactobacillus casei [63].”
Kang, S., Lee, S.-A., Choi, S., Park, Y., & Kim, D. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110104
Molecular mechanisms involved in the anticancer activities of probiotics and postbiotics
Rocchetti, M. T., Mangieri, D., Spano, G., & Fiocco, D. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04411-2
“Notably, the anticancer effect of ferrichrome is greater than that of conventional anticancer drugs, such as 5-FU or cisplatin [107].”
Liu, W., & Zhang, W. (2026) · ONCOLOGIE · doi:10.1515/oncologie-2026-0219
“Ferri-chrome secreted by Lactobacillus casei ATCC334 activated JNK – DDIT3 signaling and induced endoplasmic reticulum stress-associated apoptosis in CRC cells [104].”
Mansouri, O. A., & Bakhsh, T. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_2078_2025
Ferrichrome: bacterial function, synthetic mimics, and biomedical applications
Raether, N., Wojciechowska, M., Trylska, J., & Patenge, N. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1932981
“Most studies employed xenograft models in nude mice, which do not allow the observation of immune-related effects (Konishi et al., 2016; Ijiri et al., 2017; Kita et al., 2020; Iwama et al., 2021; Kunogi et al., 2024).”
Zhang, Y., Wang, Z., Cui, W., Wang, J., & Wang, S. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101272
Khan, A., Tareen, A., Farid, A. A. M., Amin, A., Khan, H. N., Hadi, D. K., Khan, S. R., & Raza, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1985675
Metadata
- Authors
- Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., Ikuta, K., Akutsu, H., Tanabe, H., & Kohgo, Y.
- Affiliations
- Asahikawa Medical University (JP)
- International University of Health and Welfare Hospital (JP)
- Corresponding author
- Fujiya, Mikihiro
- ORCID
- Venue
- Nature Communications
- Published
- 2016-08-10
- Volume
- 7
- Issue
- 1
- Pages
- 12365-12365
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4987524
- OpenAlex
- W2491844534
- Cited by
- 287
- References
- 20
- Citations by year
- 2026: 15 · 2025: 36 · 2024: 38 · 2023: 39 · 2022: 35 · 2021: 51 · 2020: 28 · 2019: 19 · 2018: 9 · 2017: 16 · 2016: 1
- FWCI
- 18.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Health, Labour and Welfare (26460956)
- Japan Society for the Promotion of Science (26460956, 25460923, 16H06607)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- ferrichrome, probiotics, Lactobacillus casei, colon cancer, apoptosis, JNK signaling, c-Jun N-terminal kinase, tumor suppression, culture supernatant, anticancer activity, gene expression profiling
- MeSH terms
- Animals, Antineoplastic Agents, Cell Survival, Cisplatin, Colon, Colonic Neoplasms, Ferrichrome, Fluorouracil, Humans, Lacticaseibacillus casei, Male, Mice, Inbred BALB C, Mice, Nude, Mass Spectrometry, Up-Regulation, Treatment Outcome, Apoptosis, Disease Progression, Probiotics, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, JNK Mitogen-Activated Protein Kinases, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.